Investing in Tomorrow's Health

NCL Technology Ventures invests transformational equity capital in entrepreneurs who have truly innovative technologies.

Our Investment Strategy

We invest in Seed and Series A rounds where we can deploy our expertise and capital to help our companies achieve an early inflection point in valuation. We consciously choose investments that create an impact on the lives of patients as well as financial return for our investors.

Our Value Add:

We provide a package of human and capital resources over the life of our investments including:

  • – Strong scientific knowledge and frontline healthcare experience
  • – Developmental and leadership building experience
  • – A carefully built local and global network of healthcare specialists
  • – An overriding ambition to succeed in bringing new innovation in healthcare to benefit global recipients

 We are pleased with the performance of Fund 1 and have therefore decided to back Fund 2 as a cornerstone investor.”

– Health Technology Fund II LP

Our Portfolio

Our investments keep making strides in their fields and winning awards in recognition.

All Digital Health Medical Technologies Therapeutics
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo
Client's company logo

NCLs Health Technology Fund II

NCL has recently launched it Health Technology Fund II.  The fund has been designed to take positions in pioneering new technologies that can create significant patient impact and produce upper quartile investment returns.

The fund has launched in partnership with several leading UK institutions including Kings College, NHS and our delivery partner Catalent Inc (NYSE: CLT). Documentation can be provided to professional investors only upon request.

Whether a potential investor or an entrepreneur we invite you to discuss your goals and ambitions with us.

Our Team

Our team spans three generations and is vastly experienced in venture investment, fund structuring, entrepreneurship and business management and is supported by an expert Scientific Advisory Board.

All Board of Directors International Investment Team Scientific Advisory Board Support Team
Jerry Biggs's headshot

Jerry Biggs

CEO
View Profile
Emma Sugrue's headshot

Emma Sugrue

Executive Assistant
View Profile
Jonathan Synett's headshot

Jonathan Synett

CIO
View Profile
Katerina Sanchez Schilling's headshot

Katerina Sanchez Schilling

Investment Manager
View Profile
Nicholas Ibery's headshot

Nicholas Ibery

General Partner & Global Head of Healthcare Investments
View Profile
Maria Konovalova's headshot

Maria Konovalova

Investment Analyst
View Profile
Pat O’Neill's headshot

Pat O’Neill

President - US Operations
View Profile
Graham Hutchins's headshot

Graham Hutchins

Operations Director
View Profile
Chris Phillips's headshot

Chris Phillips

Executive Advisor
View Profile
Jon Scott-Maxwell's headshot

Jon Scott-Maxwell

Non-Executive Director
View Profile
Professor Clive Page's headshot

Professor Clive Page

View Profile
Professor Michelle Garrett's headshot

Professor Michelle Garrett

View Profile
Martin Riley's headshot

Martin Riley

View Profile
Julien Meissonnier's headshot

Julien Meissonnier

View Profile
Professor John Wood CBE FREng's headshot

Professor John Wood CBE FREng

View Profile
Graeme Cox's headshot

Graeme Cox

View Profile

Our News

NCL is UK Lead of $6M Series A for Curesponse

NCL is delighted to welcome Curesponse to our portfolio, a breakthrough cancer precision medicine company. Their platform, cResponse, accurately and quickly predicts a patient’s … Continued

Read more

TC BioPharm to begin trialling T-cell therapy against Covid-19

Fantastic to see the Telegraph and the Daily Mail covering the work of TC BioPharm, one of our portfolio companies. Talks with government are … Continued

Read more

Award for ALERT at product launch!

After an absolutely fantastic product launch last week, the team at Alert Technology are slowly coming back down to earth following this year’s Contamination … Continued

Read more

Want to discuss an investment opportunity with us?

Submit an Opportunity